NEURINOX Symposium on 23-24 September 2015

Here you will find slides, videos and articles from the NEURINOX symposium which took place on 23-24 September at the Molecular Biotechnology Centre in Torino, Italy.


Symposium programme.


Slides from sessions

Below can be downloaded some of the slides from the NEURINOX symposium day 1 and 2.

DAY 1: Public event dedicated to patient's associations/public/journalists

Current treatment options of Epilepsy, Frank Tennigkeit, UCB Pharma

Current treatment option of MS, Fredrik Piehl, Karolinska Institutet & Swedish MS Society

Reactive oxygen based drugs as treatment fo MS and other autoimmune diseases, Peter Olofsson, REDOXIS

DAY2: Public event devoted to the scientific and industry communities

The Nox Enzymes: an overview of their Early History through the Present Day, David Lambeth, Emory University Medical School

Genetic control of NOX2 genes crucial for regulating inflammation, Rikard Holmdahl, Karolinska Institutet

Overview of the personalised medicine of neurodegenerative disease, Adriano Chio', ALS Center, University of Torino

NOX2 pathway modulation in naimal models of neuro autoimmune diseases, Malin Hultqvist, REDOXIS

GKT drug development, Jeanette Wood, Genkytox

Therapeutic strategies to ameliorate iron toxicity in Alzheimer's and Parkinson's diseases, Roberta J Ward, Université Catholique de Louvain and Imperial College


Student's videos

High school and undergraduate students had been invited to participate in specifically designed activities at the symposium. Videos produced by the students are presented below:

The contribution of NEURINOX to Multiple Sclerosis: 

NEURINOX symposium Torino 2015 - blog:

NEURINOX symposium Torino 2015 and career perspectives:

Neurinox Symposium: on innovative concepts for treating neurodegenerative diseases:

Video on Epilepsy:

Video on Epilepsy: